InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: gemmill post# 9344

Monday, 03/03/2014 12:31:49 PM

Monday, March 03, 2014 12:31:49 PM

Post# of 48316
Yes $ONCS has definitely treated the patients as they enroll. That is why Merkel Cell and Cutaneous have early results. These two cancers are rare but deadly and there has been difficulty earlier in finding all the Patients. So they were treated as they came. No need to wait. Both clinical trials are expected to complete their full enrollment this year.